Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?

Oncolytics Biotech Ownership Summary

Oncolytics Biotech is owned by 1.37% institutional investors, 2.98% insiders, and 95.65% retail investors. Morgan stanley is the largest institutional shareholder, holding 0.42% of ONCY shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oncolytics Biotech	1.37%	2.98%	95.65%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	426.52K	0.42%	$372.78K
Marshall wace, llp	323.98K	0.36%	$453.57K
Seeds investor	258.31K	0.26%	$225.76K
International assets investment management	208.15K	0.21%	$181.92K
Citadel advisors	137.09K	0.18%	$135.71K
Goldman sachs group	169.90K	0.17%	$148.49K
Quadrature capital	106.08K	0.12%	$146.38K
Royal bank of canada	68.23K	0.07%	$96.00K
Tocqueville asset management	72.00K	0.07%	$62.93K
Cibc world market	70.41K	0.07%	$61.26K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ground swell capital	34.40K	0.06%	$30.06K
Seeds investor	258.31K	0.04%	$225.76K
Ball & co wealth management	38.25K	0.02%	$33.00K
International assets investment management	208.15K	0.01%	$181.92K
Vantage point financial	29.74K	0.01%	$26.00K
Scientech research	18.20K	0.01%	$25.49K
Headinvest	44.70K	0.01%	$39.07K
Brave asset management	25.00K	0.01%	$21.85K
Seacrest wealth management	32.00K	0.00%	$30.74K
Professional advisory services	20.00K	0.00%	$17.00K

Top Buyers

Holder	Shares	% Assets	Change
Marshall wace, llp	323.98K	0.00%	323.98K
Quadrature capital	106.08K	0.00%	106.08K
Tocqueville asset management	72.00K	0.00%	72.00K
Cibc private wealth group	50.00K	0.00%	50.00K
Morgan stanley	426.52K	-	43.17K

Top Sellers

Holder	Shares	% Assets	Change
Virtu financial	-	-	-98.45K
Millennium management	-	-	-40.89K
Long focus capital management	-	-	-40.00K
Goldman sachs group	169.90K	-	-38.80K
Citadel advisors	137.09K	-	-25.68K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	323.98K	0.00%	323.98K	$453.57K
Quadrature capital	106.08K	0.00%	106.08K	$146.38K
Tocqueville asset management	72.00K	0.00%	72.00K	$62.93K
Cibc private wealth group	50.00K	0.00%	50.00K	$43.70K
Ground swell capital	34.40K	0.06%	34.40K	$30.06K

Sold Out

Holder	Change
Russell investments group	-1.00
Pacifica partners	-100.00
Ifp advisors	-100.00
Ameritas advisory services	-750.00
Beaird harris wealth management	-825.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	36	-35.71%	1,385,405	-50.88%	1	14.24%	9	-52.63%	2	-71.43%
Sep 30, 2025	30	-43.40%	910,881	-32.37%	1	39.52%	5	-76.19%	2	-60.00%
Jun 30, 2025	55	12.24%	1,492,518	10.47%	1	55.94%	23	9.52%	5	-28.57%
Mar 31, 2025	50	8.70%	1,365,517	3.85%	1	60.09%	22	-8.33%	7	-
Dec 31, 2024	27	-35.71%	736,398	-38.42%	-	39.18%	14	-	2	-77.78%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	66.94K	0.06%	-
Vifag 2002 SICAV	30.00K	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 12, 2026	Kelly Jared	Chief Executive Officer	Buy	$24.84K
Feb 11, 2026	Kelly Jared	Chief Executive Officer	Buy	$4.68K
Feb 12, 2026	Look Kirk	Chief Financial Officer	Buy	$10.10K
Feb 12, 2026	Pisano Wayne	-	Buy	$25.34K
Feb 12, 2026	Heineman Thomas Charles	Chief Medical Officer	Buy	$10.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	12	-

ONCY Ownership FAQ

Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 1.37%, followed by 2.98% insiders and 95.65% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 381.47%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Morgan stanley (426.52K shares, 0.42%), Marshall wace, llp (323.98K shares, 0.36%), and Seeds investor (258.31K shares, 0.26%). Together, they hold 1.03% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Ground swell capital is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 34.4K Oncolytics Biotech shares, valued at 30.06K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Oncolytics Biotech shares, with 0.06% of its total shares outstanding invested in 66.94K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools